COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.
复制标题
DOI：
10.1016/s2665-9913(22)00001-7
复制
发表时间：
2022-04
期刊：
影响因子：
--
通讯作者：
Simard JF
中科院分区：
文献类型：
--
作者：
Putman M;Kennedy K;Sirotich E;Liew JW;Sattui SE;Moni TT;Akpabio AA;Alpizar-Rodriguez D;Angevare S;Beesley RP;Berenbaum F;Bulina I;Chock YPE;Conway R;Duarte-García A;Singh AD;Duff E;Durrant KL;Gheita TA;Hill CL;Howard R;Hoyer BF;Hsieh E;El Kibbi L;Kilian A;Kim AHJ;Liew DFL;Lo C;Mateus EF;Miller B;Mingolla S;Nudel M;Singh JA;Singh N;Ugarte-Gil MF;Wallace J;Young KJ;Zamora-Tehozol EA;Bhana S;Costello W;Grainger R;Machado PM;Robinson PC;Sufka P;Wallace ZS;Yazdany J;Harrison C;Larché MJ;Levine M;Foster G;Thabane L;Hausmann JS;Sparks JA;Simard JF
在广泛开展疫苗接种计划之前，新冠肺炎接种后的潜在副作用和红斑是风湿病患者对疫苗犹豫不决的常见原因。3、4研究目的是描述风湿病患者对接种新冠肺炎疫苗的看法和行为，并确定最有可能影响他们接种意向的信息来源。其他地方介绍了全球风湿病联盟疫苗调查(附录16-93)。5简而言之，这项调查是利用多个患者合作伙伴的意见以协作和迭代的方式构建的，并于2021年4月2日以英语在全球推出。随后发布了11个译文(意大利语、希伯来语、法语、旁遮普语、俄语、西班牙语、阿拉伯语、繁体中文[普通话]、土耳其语、简体中文、印地语)。风湿病学家和面向患者的组织在社交媒体和C19-GRA网站上传播了这项调查。这项调查是匿名的，该项目得到了波士顿儿童医院机构审查委员会的批准，参与者在调查开始时提供了同意。这项分析包括来自102个国家的7,005名接种疫苗和未接种疫苗的受访者，他们年龄在18岁或以上，并提供了同意，报告了一种或多种风湿病(不包括骨关节炎和纤维肌痛)，并完成了整个调查(2021年4月2日至7月5日；附录第2页)。我们问道：“如果你现在就能免费获得一种被批准的预防新冠肺炎的疫苗，你会同意接种吗？”回答“是的，我已经接受了至少一剂”或“是的，当它可用时我会得到”的受访者被归类为愿意。那些回答“否”的人被归类为不愿意，其余的被选为“不确定”，并被归类为不确定。接种意愿也是在视觉模拟评分上进行测量的，从0到10，0表示完全不愿意，10表示非常愿意
Before widespread vaccination programmes, potential side-effects and flares after COVID-19 vaccination were frequent reasons for vaccine hesitancy among people with rheumatic disease. 3, 4 The study objective was to describe the perceptions and behaviours of people with rheumatic disease regarding COVID-19 vaccination and to identify the information sources most likely to affect their intention to be vaccinated.The COVID-19 Global Rheumatology Alliance (C19-GRA) Vaccine Survey has been described elsewhere (appendix pp 16–93). 5 Briefly, the survey was constructed collaboratively and iteratively with input from multiple patient partners and was launched globally in English on April 2, 2021. 11 translations were subsequently released (Italian, Hebrew, French, Punjabi, Russian, Spanish, Arabic, Traditional Chinese [Mandarin], Turkish, Simplified Chinese, Hindi). Rheumatologists and patient-facing organisations disseminated the survey on social media and the C19-GRA website. The survey was anonymous, the project was approved by Boston Children’s Hospital Institutional Review Board and participants provided consent at the survey start. This analysis includes 7005 vaccinated and unvaccinated respondents from 102 countries who were aged 18 years or older and provided consent, reported one or more rheumatic disease (excluding osteoarthritis and fibromyalgia), and completed the entire survey (April 2 to July 5, 2021; appendix p 2). We asked,“If one of the approved vaccines to prevent COVID-19 was available to you right now at no cost, would you agree to be vaccinated?”. Respondents answering,“Yes, I have already received at least one dose”, or “Yes, I will get it when it is available”, were classified as willing. Those answering,“No”, were classified as unwilling, and the remainder selected,“Unsure”, and were classified as unsure. Vaccination willingness was also measured on a visual analogue scale from 0 to 10, with 0 indicating not willing at all and 10 very willing